Table 2.
Frequency of toxicity events after the first cycle of induction chemotherapy (n = 179)
| Variables | Number | % |
|---|---|---|
| Grade III + hematological adverse events | 35 | 19.5 |
| Neutropenia | 34 | 19 |
| Anemia | 2 | 1.1 |
| Thrombocytopenia | 0 | 0 |
| Grade III + non-hematological adverse events | 1 | 0.6 |
| Acute liver injury | 0 | 0 |
| Acute kidney injury | 1 | 0.6 |
| Grade III + hematological and non-hematological adverse events | 35 | 19.6 |
| Subsequent chemotherapy dose reduction more than 50% | 0 | 0 |
| Postponement of chemotherapy > = 4 days | 9 | 5 |
| Death during or after chemotherapy | 8 | 4.5 |
| Overall DLT events | 43 | 24 |
Abbreviation: DLT events Dose-limiting toxicity events